Cisplatin Plus Raltitrexed or 5-fluorouracil Concurrent With Radiotherapy for Head and Neck Squamous Cell Cancer
Status:
Unknown status
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
This study is a multicenter phase Ⅲ trial. The objective is to compare the efficacy and
toxicity of cisplatin plus raltitrexed or 5-fluorouracil in concurrence with IMRT for
patients with locoregionally advanced head and neck squamous cell cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Jiangsu Cancer Institute & Hospital
Collaborators:
Affiliated Hospital of Jiangnan University Changzhou Cancer Hospital Changzhou Cancer Hospital of Soochow University Nanjing BenQ Hospital Nanjing Cancer Hospital Northern Jiangsu Province People's Hospital The First Affiliated Hospital with Nanjing Medical University The Second Hospital of Nanjing Medical University Wuxi Cancer Hospital